SCHEMBL4898047

SCHEMBL4898047

CCN(c1ccc(Oc2ccc(F)cc2)cc1)S(=O)(=O)c1cc(C)c(C)c(C(=O)OC)c1

nearest known ligand 0.47

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.47
TSHR P16473 3/20 0.44
KMT2A Q03164 2/20 0.44
MAPK1 P28482 2/20 0.44
HSD17B10 Q99714 1/20 0.44
LMNA P02545 2/20 0.43
NR3C1 P04150 1/20 0.43
NPSR1 Q6W5P4 2/20 0.40
ESR1 P03372 1/20 0.40
HDAC8 Q9BY41 1/20 0.40
ALDH1A1 P00352 3/20 0.40
POLB P06746 2/20 0.40
CETP P11597 1/20 0.40
MMP2 P08253 1/20 0.39
MMP9 P14780 1/20 0.39
ATM Q13315 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4908351 0.91 LMNA (0.45) MAPTTSHRLMNANPSR1ESR1
SCHEMBL4903956 0.91 ESR1 (0.48) MAPTLMNANR3C1ESR1ALDH1A1
SCHEMBL4904184 0.90 HCRTR2 (0.50) MAPTMAPK1LMNANR3C1NPSR1
SCHEMBL4904286 0.90 MAPT (0.45) MAPTTSHRKMT2ALMNANR3C1
SCHEMBL4906457 0.90 MCL1 (0.41) MAPTTSHRLMNANR3C1NPSR1
SCHEMBL4906264 0.90 LMNA (0.52) TSHRKMT2AMAPK1HSD17B10LMNA
SCHEMBL4904039 0.89 KEAP1 (0.47) MAPTTSHRKMT2AMAPK1HSD17B10
SCHEMBL4906417 0.89 HDAC8 (0.52) MAPTMAPK1NPSR1HDAC8POLB
SCHEMBL4906191 0.89 MMP9 (0.41) MAPTTSHRKMT2ALMNANR3C1
SCHEMBL4903997 0.89 MAPT (0.49) MAPTTSHRKMT2AMAPK1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20060229363-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds HAMANAKA ERNEST S 2006-10-12 US disclosed
US-20050288340-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER INC 2005-12-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060229363-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds PPARA, PPARG, PPARD MAPT 1858/4885TSHR 412/4885KMT2A 3602/4885
US-20050288340-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PPARA, PPARG, PPARD MAPT 1786/4885TSHR 400/4885KMT2A 3530/4885
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PPARA, PPARG, PPARD MAPT 1786/4885TSHR 400/4885KMT2A 3530/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.